379 A first in human phase I study of the proteasome inhibitor CEP-18770 in patients (pts) with advanced solid tumors, non-Hodgkin's lymphomas (NHL) and multiple myeloma (MM)

✍ Scribed by C. Sessa; G. Martinelli; D. Hess; A. Delmonte; C. Noberasco; S. Sammassimo; E. Gallerani; S. Marsoni; G. Camboni; F. de Braud

• Book ID: 119603062
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 48 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)72086-3